Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

NCT01475552 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Abciximab
DRUG: control

Sponsor

Seoul National University Bundang Hospital